AI Analysis

How does AAREYDRUGS.NS make money? Does AAREYDRUGS.NS have pricing power? What's the Earnings Whisper? Will AAREYDRUGS.NS profit more as the business scales? What is AAREYDRUGS.NS's management track record? Is AAREYDRUGS.NS's current price justified?

Aarey Drugs & Pharmaceuticals Limited

₹113 +$45.45 (+67.28%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹108.74

Day Range

₹105.21₹113.5

Year Range

₹50.31₹113.5

Market Cap

3.2B

AVG Volume

144.31K

Trailing/Forward PE

76.87/-

PEG ratio

-113.77

Dividend Yield

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

AAREYDRUGS.NS Revenue (INR) by year
Period	Revenue (INR)
2026	4.72B
2025	4.74B
2024	3.96B
2023	4.14B
2022	4.92B
2021	3.32B
2020	3B
2019	3.55B
2018	3.49B
2017	3.96B

Net Income (INR) · A

AAREYDRUGS.NS Net Income (INR) by year
Period	Net Income (INR)
2026	45.22M
2025	40.24M
2024	55.69M
2023	37.71M
2022	65.45M
2021	63.14M
2020	57.94M
2019	65.42M
2018	61.77M
2017	58.82M

Operating Income (INR) · A

AAREYDRUGS.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	43.22M
2025	40.05M
2024	35.89M
2023	65.28M
2022	108.42M
2021	37.25M
2020	23.55M
2019	69M
2018	71.38M
2017	84.45M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Aarey Drugs & Pharmaceuticals Limited

Video analysis: AAREYDRUGS.NS

News: AAREYDRUGS.NS

Similar companies